InvestorsHub Logo
Followers 11
Posts 903
Boards Moderated 0
Alias Born 12/19/2005

Re: DFRAI post# 151

Wednesday, 03/23/2016 6:47:16 PM

Wednesday, March 23, 2016 6:47:16 PM

Post# of 977
Dug around in AACR. Notes here:

2016 AACR

Nothing earth shattering from Trillium. Other teams figuring which combos are likely to work for which cancers, which does help.

Keep an eye on the Novimmune bispecific. It's a year behind, but looks more competitive than the Stanford effort, IMO. A stumble by TRIL could hurt if it allows this program to catch up or bypass.

Regards, RockRat